Screening for Heart Failure in Patients with Hypertension And/Or Diabetes Using Hand-Held Echocardiography: A Pilot Study. [PDF]
Yang ZX+8 more
europepmc +1 more source
C-Type Natriuretic Peptide Modulates Permeability of the Blood–Brain Barrier
Manoj Bohara+5 more
semanticscholar +1 more source
Discovering new hub genes of dilated cardiomyopathy
Abstract Aims Dilated cardiomyopathy (DCM) has a poor prognosis and exhibits a complex and diverse aetiology and genetic profile. The genes responsible for the pathogenesis of DCM have not been fully identified. The present study aimed to explore new hub genes of DCM by mining the human DCM databases and further by experimental validation.
Jun‐Yan Zhu+9 more
wiley +1 more source
Effectiveness of Atrial Natriuretic Peptide in the Treatment of Critically Ill Patients: A Systematic Review and Meta-Analysis. [PDF]
Odutola PO, Olarewaju A, Shah P.
europepmc +1 more source
The H2‐Registry: overview, first results and outlook. Abstract Aims Heart failure (HF) is a highly prevalent condition affecting 1–3% of the adult population in Europe. Despite landmark improvements in HF care over the last two decades, hospitalization and mortality rates remain relatively high.
Johannes Leiner+15 more
wiley +1 more source
Extraordinarily High Brain Natriuretic Peptide (BNP) Level in a Case of Thyroid Storm. [PDF]
Ishii H, Ohashi K.
europepmc +1 more source
Signs of congestion, quality of life and short‐term rehospitalization in patients with heart failure
Abstract Aims Signs of congestion are a treatment target in patients with heart failure (HF), as they affect patients' well‐being, and congestion scores are associated with the risk of early readmission. However, which individual sign of congestion has the strongest association with quality of life (QoL) and HF rehospitalization remains uncertain ...
Geert H.D. Voordes+4 more
wiley +1 more source
Iron deficiency in heart failure: Epidemiology, diagnostic criteria and treatment modalities
ESC Heart Failure, Volume 12, Issue 2, Page 723-726, April 2025.
Stephan von Haehling
wiley +1 more source
Abstract Aims Two general phenotypes of heart failure (HF) are recognized: HF with reduced ejection fraction (HFrEF) and with preserved EF (HFpEF). To develop phenotype‐specific approaches to treatment, distinguishing biomarkers are needed. The goal of this study was to utilize quantitative metabolomics on a large, diverse population to replicate and ...
Fawaz Naeem+13 more
wiley +1 more source
Brain natriuretic peptide and all-cause mortality in patients treated with haemodialysis. [PDF]
Svensson MK+5 more
europepmc +1 more source